Now recruiting
Select your nearest location above for the full list of local trials, or scroll though the latest studies below.
Looking for participants aged 18-70 years old that have suffered gout for more than 2 years to help investigate the use of the Investigational Product, a local, topically administered NSAID. The goal of topical administration within this study is that by targeting treatment to only the area of flare-up, the inflammation and pain of a gout flare can both be treated, while potentially reducing the systemic side effects of oral NSAIDs.
A Phase 4 Clinical Trial Comparing the Effectiveness of Fluticasone Furoate/Umeclidinium Bromide/Vilanterol Trifenatate (FF/UMEC/VI) on Lung Function and Asthma Control in Adults with Uncontrolled Asthma Compared to the Usual Standard of Inhaled Corticosteroids/Long-Acting Beta-2 Agonists (ICS/LABA).
A Phase 4 Clinical Trial Comparing the Effectiveness of Fluticasone Furoate/Umeclidinium Bromide/Vilanterol Trifenatate (FF/UMEC/VI) on Lung Function and Asthma Control in Adults with Uncontrolled Asthma Compared to the Usual Standard of Inhaled Corticosteroids/Long-Acting Beta-2 Agonists (ICS/LABA).
A Phase 4 Clinical Trial Comparing the Effectiveness of Fluticasone Furoate/Umeclidinium Bromide/Vilanterol Trifenatate (FF/UMEC/VI) on Lung Function and Asthma Control in Adults with Uncontrolled Asthma Compared to the Usual Standard of Inhaled Corticosteroids/Long-Acting Beta-2 Agonists (ICS/LABA).
A Phase 4 Clinical Trial Comparing the Effectiveness of Fluticasone Furoate/Umeclidinium Bromide/Vilanterol Trifenatate (FF/UMEC/VI) on Lung Function and Asthma Control in Adults with Uncontrolled Asthma Compared to the Usual Standard of Inhaled Corticosteroids/Long-Acting Beta-2 Agonists (ICS/LABA).
A Phase 2 Clinical Trial Evaluating the Effectiveness of Alnylam’s potential New Add-On Treatment Zilebesiran versus Placebo on Blood Pressure Control in Adults with High Cardiovascular Risk that are currently taking two or more Anti-Hypertensive Treatments.
A Phase 3 Clinical Trial Comparing the Effectiveness of a New Investigational Treatment with Tirzepatide in Managing Type 2 Diabetes Glycaemic Control and Weight Reduction.
A Phase 3 Clinical Trial Comparing the Effectiveness of a New Investigational Treatment with Tirzepatide in Managing Type 2 Diabetes Glycaemic Control and Weight Reduction.
Research study investigating a new cholesterol medication on reducing cardiovascular events in individuals living with, or at risk of cardiovascular disease.
Research study investigating a new cholesterol medication on reducing cardiovascular events in individuals living with, or at risk of cardiovascular disease.
A Randomised, Double-Blind, Placebo-Controlled, Parallel-Arm Study to Evaluate the Efficacy, Safety and Tolerability of 150 mg Sublingual Cannabidiol in Adults with Mild-to-Moderate Pain.
A Randomised, Double-Blind, Placebo-Controlled, Parallel-Arm Study to Evaluate the Efficacy, Safety and Tolerability of 150 mg Sublingual Cannabidiol in Adults with Mild-to-Moderate Pain.
A Randomised, Double-Blind, Placebo-Controlled, Parallel-Arm Study to Evaluate the Efficacy, Safety and Tolerability of 150 mg Sublingual Cannabidiol in Adults with Mild-to-Moderate Pain.
A Randomised, Double-Blind, Placebo-Controlled, Parallel-Arm Study to Evaluate the Efficacy, Safety and Tolerability of 150 mg Sublingual Cannabidiol in Adults with Mild-to-Moderate Pain.
Are you interested in participating in clinical trials?
We value your privacy and are committed to protecting your data and personal information.
